Agreement also gives Funakoshi rights to promote ReachBio's contract cell biology research services.
SEATTLE, Nov. 12, 2014 /PRNewswire/ — ReachBio Research Labs (a registered trade name of ReachBio LLC, Seattle, WA) announced today that it has signed an agreement with Funakoshi Co., Ltd. (Tokyo, Japan), giving Funakoshi non-exclusive distribution rights to ReachBio's human primary cell product line for the life science research market within Japan. Under a companion agreement, Funakoshi will also promote ReachBio's specialized contract research services to Japanese drug development companies.
Photo – http://photos.prnewswire.com/prnh/20141111/157946LOGO
ReachBio Research Labs provides research products and contract services for applications in basic life science research, drug research & development and toxicology. The company's cryopreserved normal human primary cells are isolated from blood, cord blood and bone marrow and include minimally processed mononuclear cells and highly purified subsets such as T lymphocytes, B lymphocytes, natural killer cells and monocytes. It also includes "ReachBio Qualified ™ " CD34+ and CD133+ stem cells from cord blood and bone marrow that are functionally pre-qualified in colony-forming cell assays. ReachBio also offers customized cell isolation services for customers with specific needs such as unique cell types, particular donor background, HLA type, repeat donors, etc.
ReachBio's specialized contract research services utilize human primary cells, particularly hematopoietic stem and progenitor cells, in in vitro assays that are highly predictive of drug efficacy and hemotoxicity.
"Funakoshi is a highly respected distributor of life science research products in Japan and we are extremely happy to have them as a distributor there, and to also have them promote our contract cell biology research services to Japanese pharma and biotechnology companies," said Rob Chaney, ReachBio's General Manager and COO. "We look forward to working with them to increase the visibility and availability of our human primary cell products and contract research services to the important Japanese life science research community."
Said Dr. Ryoya Funakoshi, President and CEO of Funakoshi, "We are very happy to be distributing ReachBio Research Labs' normal human cell products and to also be able to offer their customized cell isolation services and contract research services to our valued customers in Japan. We believe that their high quality products and specialized services will be very well received by Japanese researchers and we anticipate a very productive relationship with ReachBio."
About ReachBio Research Labs
ReachBio LLC is a life sciences organization based in Seattle, WA. It provides specialized primary cell biology contract research services and products to biopharmaceutical, biotechnology, and related organizations worldwide under its registered trade name ReachBio Research Labs.
About Funakoshi Co., Ltd.
Funakoshi Co., Ltd is based in Tokyo, Japan and is a local distributor of high quality life science research tools and reagents.
Contact Info
For ReachBio
ReachBio LLC
123 NW 36th St., Seattle, WA 98107
Phone: 206-420-0300
Fax: 206-420-0301
Email
www.reachbio.com
For Funakoshi
FUNAKOSHI Co. Ltd.,
9-7 Hongo 2-chome, Bunkyo-ku,
Tokyo 113-0033, Japan
Phone: +81-3-5684-1620
Fax: +81-3-5684-1775
Email
www.funakoshi.co.jp